Cerebrospinal Fluid Leak Clinical Trial
Official title:
Flat Bed Rest vs. Immediate Mobilisation After Incidental Durotomy During Lumbar Spinal Surgery: A Prospective Randomised Trial
Patients with persistent symptoms of cerebrospinal-fluid leakage (positional headache,
photophobia, nausea and vomiting, clear drainage from the wound, fluctuant subcutaneous
wound) after a primary repair should be considered for revision surgery to avoid potentially
serious complications including CSF (cerebro spinal fluid) fistula formation. Prolonged bed
rest immediatel after reapir of an ID () incidental durotomy) is widely accepted and
frequently applied. current literature provides supporting retrospective evidence that
prolonged bed rest may not be required after watertight closure of dural tears.
The purpose of this study is to further investigate the impact of prolonged bed rest on the
need for early reoperation following primary repair of an ID after lumbar spinal surgery.
The primary endpoint of this study is the difference in reoperation rate between the two
study groups to further investigate if either one or the other postoperative mobilisation
regimen provides a significant benefit in terms of persistent dural leakage.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | May 2017 |
Est. primary completion date | April 2017 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 99 Years |
Eligibility |
Inclusion Criteria: All patients over the age of 18 years with an ID sustained during a primary or revision lumbar spinal procedure at our institution are the subject of this prospective, randomised analysis. Exclusion Criteria: Patients referred for repair of an externally sustained ID, cases in which durotomy was not primarily recognised and repaired as well as patient who refuse to sign informed consent are going to be excluded from this analysis. Informed consent is going to be obtained one day prior to index procedure. Further Intervention because of Spondylitis/Spondylodiscitis, Tumor, Trauma. Pregnant patients |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospital Balgrist | Zurich |
Lead Sponsor | Collaborator |
---|---|
Balgrist University Hospital |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reoperation rate | The primary endpoint of this study is the difference in reoperation rate between the two study groups to further investigate if either one or the other postoperative mobilisation regimen provides a significant benefit in terms of persistent dural leakage. | 6 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04057157 -
Post-market Assessment of Biodesign Dural Repair Grafts
|
||
Withdrawn |
NCT02902133 -
Acetazolamide to Prevent Post Operative CSF Leak
|
Phase 2 | |
Completed |
NCT03566602 -
Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
|
N/A | |
Completed |
NCT02891070 -
Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery
|
Phase 3 | |
Recruiting |
NCT04490629 -
The Efficacy and Safety of a Latest Dural Substitute
|
N/A | |
Withdrawn |
NCT04351061 -
Acetazolamide for the Prevention of Post Operative CSF Leak
|
Phase 2 | |
Recruiting |
NCT04086550 -
Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
|
N/A | |
Completed |
NCT02457546 -
The EVICEL® Neurosurgery Phase III Study
|
Phase 3 | |
Completed |
NCT04145544 -
A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair.
|
N/A | |
Completed |
NCT04124523 -
Perioperative CSF Leak Management - an Opinion Study
|
||
Active, not recruiting |
NCT04923867 -
Suturable DuraGen™ PMCF Study
|
||
Withdrawn |
NCT03181464 -
Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics
|
Phase 4 |